<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">MEAJO</journal-id>
      <journal-title-group>
        <journal-title>Middle East African Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0974-9233</issn>
      <issn pub-type="epub">0975-1599</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25624689</article-id>
      <article-id pub-id-type="pmc">4302469</article-id>
      <article-id pub-id-type="publisher-id">MEAJO-22-125</article-id>
      <article-id pub-id-type="doi">10.4103/0974-9233.148364</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Conjunctival Necrosis Following a Subconjunctival Injection of Triamcinolone Acetonide in a Child</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ying-Jiun</surname>
            <given-names>Chong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chee-Kuen</surname>
            <given-names>Wong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shatriah</surname>
            <given-names>Ismail</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia</aff>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding Author:</bold> Prof. Dr. Shatriah Ismail, Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia. E-mail: <email xlink:href="shatriah@usm.my">shatriah@usm.my</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2015</year>
      </pub-date>
      <volume>22</volume>
      <issue>1</issue>
      <fpage>125</fpage>
      <lpage>128</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Middle East African Journal of Ophthalmology</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Conjunctival necrosis is a rare complication following periocular/intraocular triamcinolone acetonide injection and has been reported extensively in adults. We describe a child who developed conjunctival necrosis following subconjunctival injection of triamcinolone acetonide for severe chronic anterior uveitis. Prompt diagnosis and management of this uncommon condition is vital.</p>
      </abstract>
      <kwd-group>
        <kwd>Children</kwd>
        <kwd>Conjunctival Necrosis</kwd>
        <kwd>Subconjunctival Injection</kwd>
        <kwd>Triamcenolone Acetonide</kwd>
        <kwd>Uveitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>INTRODUCTION</title>
      <p>Conjunctival ischemia and necrosis following periocular/intraocular injection of methylprednisolone, triamcinolone acetonide, and betamethasone had been reported in adult patients.<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref> Based on a PubMed search, there is one similar complication reported in the pediatric age group recently.<xref rid="ref9" ref-type="bibr">9</xref> We described a child who displayed signs of conjunctival necrosis 2 weeks after a subconjunctival injection of triamcinolone acetonide for recurrent attack of anterior uveitis. It is essential to highlight this uncommon complication of periocular corticosteroid injection in children.</p>
    </sec>
    <sec id="sec1-2">
      <title>CASE REPORT</title>
      <p>A mother had noted that her daughter started to have recurrent redness, discomfort, and photophobia in both eyes since she was two and half years of age. Six months after the onset, she was examined in a tertiary hospital and parents were informed that she had severe anterior uveitis in both eyes that had complicated with secondary cataract.</p>
      <p>Her visual acuity was 6/60 in both eyes with evidence of posterior subcapsular cataract bilaterally. The conjunctiva was white. The cornea was clear in both eyes with no sign of band keratopathy. The anterior chamber appeared quiet and no iris nodules were documented. The pupil was fairly round with few sites of anterior synechiae observed. The intraocular pressure was within normal. The fundus view was hazy in both eyes. All laboratory investigations including antinuclear antibody and rheumatoid factor were negative. No radiological examination was performed because she was asymptomatic. The parent consented for lens aspiration and intraocular lens implantation in her right eye and followed with the similar operation in her left eye 3-months apart. Both the operations were uneventful.</p>
      <p>Subsequently, her visual acuity deteriorated to 6/36 in the right eye and counting fingers in the left eye. Postoperatively, there was persistent anterior uveitis, presence of dense membrane anterior to the intraocular lenses in both eyes, formation of posterior synechiae between the iris and lens, and elevated intraocular pressure. The view of the optic disc and retina was obscured. The B scan ultrasound revealed flat retina in both eyes.</p>
      <p>She was treated with syrup prednisolone 1 mg/kg/body weight, gutt predforte every 2 hourly, gutt tropicamide 0.5% every 12 hourly, and gutt timolol 0.5% 12 hourly in both eyes. Her parents agreed for synechiolysis procedure and removal of the membrane covering the pupil in her left eye under general anesthesia. The operation was uneventful. A subconjunctiva triamcinolone acetonide 20 mg (0.5 ml) was injected at the inferonasal aspect of the conjunctiva in the operated eye at the end of the procedure.</p>
      <p>At 1 week postoperative review, a subconjunctival hemorrhage was noted that corresponded with the previous site of injection given. A week later, an area of conjunctival necrosis measuring about 5 &#xD7; 3 mm was observed at the similar site [<xref ref-type="fig" rid="F1">Figure 1</xref>]. The base showed gray-to-white scleral layer with no uveal show. There surrounding conjunctiva was mildly congested. No evidence of scleral inflammation was noted. The patient was started on topical moxifloxacin every 6 hourly in the affected eye.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Anterior segment photograph shows conjunctival necrosis developed 2 weeks after the subconjunctival injection of triamcenolone acetonide</p>
        </caption>
        <graphic xlink:href="MEAJO-22-125-g001"/>
      </fig>
      <p>There was a gradual clinical improvement observed 2-weeks later. The new conjunctiva has growing with pinkish appearance. The base of the ulcer appeared clean with evidence of scleral vascularization [<xref ref-type="fig" rid="F2">Figure 2</xref>]. The conjunctival reepithelialization occurred from the edge of the surrounding healthy conjunctiva tissue. The conjunctiva necrosis was completely healed after 10 weeks and overlying conjunctiva was fully restored [<xref ref-type="fig" rid="F3">Figure 3</xref>]. Topical moxifloxacin were discontinued. She has been monitored closely for 9 months and the conjunctiva had healed completely.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Clinical improvement after 2 weeks of medical treatment</p>
        </caption>
        <graphic xlink:href="MEAJO-22-125-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>A complete recovery of conjunctival necrosis</p>
        </caption>
        <graphic xlink:href="MEAJO-22-125-g003"/>
      </fig>
      <p>Her visual acuity remained 6/60 in the right eye and counting finger at 3 feet in the left eye. Both the intraocular lenses were covered by thick membrane that was worse in the left eye. The retina view remained hazy in both eyes. The intraocular pressure remained controlled with gutt timolol 0.5% and trusopt every 12 hourly in both eyes.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>DISCUSSION</title>
      <p>Triamcinolone acetonide has been used widely in the treatment of pediatric eye diseases. These include triamcinolone-assisted vitrectomy during pediatric cataract operation, intracameral injection in pediatric cataract surgery, intravitreal injection for uveitic macular edema, periocular injection in pediatric uveitis, supratarsal injection in allergic conjunctivitis, intravitreal injections for Coat's disease, and Best vittelliform macula dystrophy.<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref></p>
      <p>Conjunctival necrosis in children following injection of triamcinolone acetonide is extremely rare. It was very unfortunate for our patient, a young girl who developed conjunctival necrosis following subconjunctival injection of triamcenolone acetonide for severe anterior uveitis. Recently, Say <italic>et al</italic>. described a child who developed perilymphatic linear subcutaneous fat atrophy and depigmentation following subtenon injection of triamcinolone acetonide.<xref rid="ref18" ref-type="bibr">18</xref></p>
      <p>The necrosis appeared localized, hypovascular, and aseptic in our patient. This is probably due to the following explanations. Firstly, corticosteroids are known to potentiate the vasoconstrictive effect of circulating catecholamines, and this may result in an area of localized conjunctiva ischemia.<xref rid="ref1" ref-type="bibr">1</xref> Secondly, conjunctival necrosis after a subconjunctival steroid injection may be due to the inactive ingredient benzyl alcohol because of its potential toxicity. Thirdly, improper dosage and injection sites with insufficient prophylactic antibiotic may play important roles in the pathogenesis.<xref rid="ref9" ref-type="bibr">9</xref> Eslampour <italic>et al</italic>. reported that deposition of steroid in the subtenon instead of subconjunctival space may prevent conjunctival toxicity.<xref rid="ref9" ref-type="bibr">9</xref> Improper site of administration such as the inferonasal bulbar conjunctiva within the interpalpebral fissure may predispose to conjunctival necrosis due to greater exposure and promixity to the lower lid margin.<xref rid="ref9" ref-type="bibr">9</xref> Low dose of topical antibiotic administration despite a high dose of steroid depot may also invite infection. Lastly, fragile conjunctiva that had been exposed to chronic usage of topical corticosteroid perhaps had facilitated the ulceration process in our patient.</p>
      <p><xref ref-type="table" rid="T1">Table 1</xref> summarizes published literature on conjunctival necrosis following corticosteroid injection, i.e. triamcinolone acetate, betamethasone, and methylprednisolone. Intensive topical antibiotic, surgical excision, debridement, and suturing have been described to treat the above conditions.<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref> The complete healing was reported ranged from 2-6 weeks in eyes with preexisting inflammatory condition.<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref8" ref-type="bibr">8</xref> Surgical excision of the necrotic tissues had reported relatively faster recovery.<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref9" ref-type="bibr">9</xref></p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Published literatures on conjunctival necrosis following corticosteroid injection</p>
        </caption>
        <graphic xlink:href="MEAJO-22-125-g004"/>
      </table-wrap>
      <p>Our observation is parallel with Agrawal <italic>et al</italic>. who treated their patients conservatively. Their patients showed complete healing with combination of topical antibiotic and antifungal regime after 2-6 weeks.<xref rid="ref2" ref-type="bibr">2</xref> Our patient responded to a single topical antibiotic and subsequently showed a complete recovery after 10 weeks. We monitored this patient closely for a possibility of secondary infection.</p>
      <p>In conclusion, conjunctival necrosis following subconjunctival triamcinolone acetonide is rare in children. We believe that chronic usage of topical and systemic corticosteroid has probably made her more susceptible to this condition. Administration of subconjunctival triamcinolone acetonide requires proper case selection and counseling as to the potential risks and benefits.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubinstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Downes</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival ischaemia subsequent to posterior subtenon's triamcinolone acetonide injection</article-title>
          <source>Eye (Lond)</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>388</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15803168</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agrawal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Agrawal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Agrawal</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival ulceration following triamcinolone injection</article-title>
          <source>Am J Ophthalmol</source>
          <year>2003</year>
          <volume>136</volume>
          <fpage>539</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">12967811</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rapuano</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Rodman</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Vander</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival necrosis following the administration of subconjunctival corticosteroid</article-title>
          <source>Ophthalmic Surg Lasers</source>
          <year>1998</year>
          <volume>29</volume>
          <fpage>79</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">9474603</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zamir</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pe&#x2019;er</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Necrotizing conjunctival ulceration following subconjunctival depot methylprednisolone injection</article-title>
          <source>Ophthalmic Surg Lasers</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>565</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">10929981</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xFC;ngor</surname>
              <given-names>IU</given-names>
            </name>
            <name>
              <surname>Beden</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Erkan</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival necrosis due to subconjunctival injection of betametasone in treatment of graft rejection after penetrating keratoplasty</article-title>
          <source>Ophthalmic Surg Lasers Imaging</source>
          <year>2005</year>
          <volume>36</volume>
          <fpage>348</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16156157</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srinivasan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival necrosis following intravitreal injection of triamcinolone acetonide</article-title>
          <source>Cornea</source>
          <year>2005</year>
          <volume>24</volume>
          <fpage>1027</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">16227858</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Zyl</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival necrosis due to subconjunctival methylprednisolone (Depo-Medrol&#x2122;) Acetate Injection</article-title>
          <source>Middle East Afr J Ophthalmol</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>385</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">21180446</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palamar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yaldiz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Egrilmez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yagci</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival necrosis due to subconjunctival depot corticosteroid injection</article-title>
          <source>TJO J</source>
          <year>2010</year>
          <volume>40</volume>
          <fpage>248</fpage>
          <lpage>50</lpage>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eslampour</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abrishami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tafaghodi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival necrosis and scleritis following subtenon triamcinolone acetonide injection</article-title>
          <source>Iran Red Crescent Med J</source>
          <year>2013</year>
          <volume>15</volume>
          <fpage>614</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">24396585</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Praveen</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Vasavada</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Dixit</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Vasavada</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Garg</surname>
              <given-names>VS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Triamcinolone-assisted vitrectomy in pediatric cataract surgery: Intraoperative effectiveness and postoperative outcome</article-title>
          <source>J AAPOS</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>340</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">20637663</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cleary</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Lanigan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>O&#x2019;Keeffe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Intracameral triamcinolone acetonide after pediatric cataract surgery</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2010</year>
          <volume>36</volume>
          <fpage>1676</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">20870112</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixit</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Vasavada</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vasavada</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Praveen</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Vasavada</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Outcomes of cataract surgery and intraocular lens implantation with and without intracameral triamcinolone in pediatric eyes</article-title>
          <source>J Cataract Refract Surg</source>
          <year>2010</year>
          <volume>36</volume>
          <fpage>1494</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">20692560</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sallam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Comer</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Grigg</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McCluskey</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children</article-title>
          <source>Arch Ophthalmol</source>
          <year>2008</year>
          <volume>126</volume>
          <fpage>200</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">18268210</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Habot-Wilner</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sallam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Roufas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kabasele</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Grigg</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>McCluskey</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periocular corticosteroid injection in the management of uveitis in children</article-title>
          <source>Acta Ophthalmol</source>
          <year>2010</year>
          <volume>88</volume>
          <fpage>e299</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">21114631</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaouali</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kahloun</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Attia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jelliti</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Trigui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yahia</surname>
              <given-names>SB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis</article-title>
          <source>Int Ophthalmol</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>99</fpage>
          <lpage>106</lpage>
          <pub-id pub-id-type="pmid">22331436</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergstrom</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Hubbard</surname>
              <given-names>GB</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease</article-title>
          <source>Retina</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>S33</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">18317342</pub-id>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cakir</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ceki&#xE7;</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Yilmaz</surname>
              <given-names>OF</given-names>
            </name>
          </person-group>
          <article-title>Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease</article-title>
          <source>JAAPOS</source>
          <year>2009</year>
          <volume>13</volume>
          <fpage>94</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Say</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Bianciotto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Perilymphatic subcutaneous fat atrophy and cutaneous depigmentation after periocular triamcinolone acetonide injection in a child</article-title>
          <source>JAAPOS</source>
          <year>2011</year>
          <volume>15</volume>
          <fpage>107</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
